Skip to content

Efficacy of transcutaneous electrical acupoint stimulation (TEAS) on early mobilization in patients undergoing percutaneous transforaminal endoscopic  discectomy: a prospective randomized controlled trial

Efficacy of transcutaneous electrical acupoint stimulation (TEAS) on early mobilization in patients undergoing percutaneous transforaminal endoscopic  discectomy: a prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000779
Enrollment
Unknown
Registered
2025-04-17
Start date
2025-05-07
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar disc herniation or lumbar spinal stenosis

Interventions

TEAS Group:TEAS Group include four points: Neiguan(PC6), Chengshan(BL57), Sanyinjiao(SP6) and Dachangshu(BL25). Self-adhesive electrodes will be sticked to above acupoints and will be connected to the
Sham Group:Sham Group include four sham points: 7 cun above and 1 cun outside Shenmen (HT7) and 9 cun above and 1 cun outside HT7
9 cun and 12 cun above the Kunlun (BL60). Self-adhesive electrodes will be sticked to these acupoints and will be connected to the acupoint nerve stimulator with no power supplied. Analog pulses will

Sponsors

People's Hospital of Beijing Daxing District
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18–75 years diagnosed at lumbar disc herniation or lumbar spinal stenosis undergoing PTED procedure regardless of gender. (2) 18 kg/m2 = BMI = 30 kg/m^2 [body mass index = weight (kg)/height (m)^2]. (3) American Society of Anesthesiologists (ASA) classification levels I–III. (4) Participating in the study voluntarily and signing informed consent.

Exclusion criteria

Exclusion criteria: (1) Surgical incision or scar in the meridian of the acupoints of Neiguan (PC6)/Chengshan (BL57)/Sanyinjiao (SP6)/Dachangshu (BL25) or sham acupoints of Kunlun (BL60)/Shenmen (HT7). (2) Local skin infection at the acupoints above. (3) Upper limb or lower limb nerve damage. (4) Participating in other clinical studies within the past 4 weeks. (5) Inability to understand the numeric rating scale (NRS) score and the visual analog scale (VAS) score. (6) Application to a pacemaker. (7) Gravida puerperant and patients with positive urine pregnancy tests. (8) Using central analgesic drugs addicted to or dependent on opioids. (9) Preoperative complications including severe CNS diseases or severe mental diseases. (10) Considered not suitable for this study.

Design outcomes

Primary

MeasureTime frame
ambulation time;

Secondary

MeasureTime frame
QOR15 scores;postoperative sng scores;postoperative VAS scores;satisfaction scores of patient;appetite recovery time of patient;

Countries

China

Contacts

Public ContactHu Chen-fu

People's Hospital of Beijing Daxing District

sinking@163.com15101018790

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026